Veracyte reported $-15479000 in Pre-Tax Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Acceleron Pharma XLRN:US $ -70.45M 6.94M
Anika Therapeutics ANIK:US $ 1.25M 7.88M
Arrowhead Research ARWR:US $ -63.37M 33.45M
Biocept BIOC:US $ 0.43M 2.26M
Bruker BRKR:US $ 121M 27.8M
Dicerna Pharmaceuticals DRNA:US $ -16.26M 24.01M
Exact Sciences EXAS:US $ -170.8M 2.09M
Genmark Diagnostics GNMK:US $ -3.7M 0.46M
Illumina ILMN:US $ 254M 82M
Immunogen IMGN:US $ -37.34M 6.6M
Intrexon XON:US $ -29.88M 9.76M
Karyopharm Therapeutics KPTI:US $ -51706000 1.74M
Laboratory Of America LH:US $ 842.8M 38.1M
Luminex LMNX:US $ 11.04M 5.81M
Rigel Pharmaceuticals RIGL:US $ -21.09M 6.3M
Sangamo Biosciences SGMO:US $ -47.6M 0.45M
Siemens SIE:GR € 1841M 133M
Sonic Healthcare SHL:AU $ 884.58M 59.42M
Veracyte VCYT:US $ -15.48M 24.67M